Clinical Trial of H2-BP Electronic Sphygmomanometer
A Prospective, Single Arm, Single Center, Non-randomized, Open Label Study to Evaluate the Accuracy of the Wrist Blood Pressure Monitor (H2-BP) Comparing With Aneroid Sphygmomanometer
1 other identifier
interventional
141
1 country
1
Brief Summary
The study compares H2-BP, a wristband blood pressure monitor, with an auscultatory sphygmomanometer. Both devices are used on the same arm. After confirming wrist and upper arm circumference, H2-BP is operated by one measurer, while the auscultatory sphygmomanometer is simultaneously operated by two other measurers. Each subject undergoes alternating measurements of H2-BP on one wrist and the auscultatory sphygmomanometer on the same arm until three valid measurement pairs are obtained per subject, with a maximum of eight repetitions allowed. The two auscultatory sphygmomanometer measurers operate independently and cannot see each other's measurements during the test. Measurements are repeated for 10 to 30 minutes until three valid blood pressure values are obtained and recorded. Validity assessment variables are derived from the recorded values to evaluate the accuracy of H2-BP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 27, 2023
CompletedFirst Submitted
Initial submission to the registry
June 30, 2024
CompletedFirst Posted
Study publicly available on registry
July 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2024
CompletedResults Posted
Study results publicly available
March 3, 2025
CompletedMarch 3, 2025
February 1, 2025
1.5 years
June 30, 2024
February 10, 2025
February 10, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Mean and Standard Deviation of Differences Between H2-BP Device and Aneroid Sphygmomanometer Measurements.
Average difference between blood pressure measurements obtained with the test medical device and the comparator. Standard deviation of the difference between blood pressure measurements obtained with the test medical device and the comparator (based on the number of measurements).
serial assessment during 1 day
Secondary Outcomes (1)
Standard Deviation of Differences Between H2-BP Device and Aneroid Sphygmomanometer Measurements.
secondary outcome will be out in 1 day
Study Arms (1)
Test subjects using H2-BP and big ben® Sphygmomanometer
EXPERIMENTALBlood Pressure Measurement with the H2-BP Electronic Sphygmomanometer (H2-BP) and with aneroid Sphygmomanometer(big ben® Sphygmomanometer).
Interventions
The patient will have the test device applied to one wrist to measure blood pressure and the control device applied to the upper arm of the same arm to measure blood pressure. 1. H2-BP: The test device is placed on the wrist and presses a button to start pressurising. When the measurement is complete, the systolic and diastolic blood pressure is displayed on the screen. 2. big ben® Sphygmomanometer: The cuff is placed on the upper arm and the pump is pressed manually to inflate. 2 measurers will measure systolic and diastolic blood pressure by connecting 2 stethoscopes separately to one cuff. Due to the external nature of the study medical device, it is not possible to blind subjects and investigators, so that subjects and measurers are aware of the allocation. Therefore, blinding of subjects and measurers will not be used in this study.
Eligibility Criteria
You may qualify if:
- Outpatients and inpatients aged 19 years or older showing hypotension, normal blood pressure, prehypertension, and hypertension
- Individuals who meet the criteria for wrist circumference, age, gender, and upper arm circumference as specified in the target number of participants.
- Those who have listened to a detailed explanation of the clinical trial, fully understand it, voluntarily decide to participate, and provide written consent to comply with precautions.
You may not qualify if:
- Patients who do not consent to participate in the study.
- Individuals who may not maintain stable blood pressure for approximately 30 minutes due to conditions resembling hypovolemia or similar conditions.
- Those who may not maintain stable blood pressure for approximately 30 minutes due to short-acting vasodilators or similar medications.
- Individuals with arrhythmia.
- Those who have eaten within 30 minutes before blood pressure measurement.
- Individuals who have consumed caffeine-containing beverages within 1 hour or smoked within 15 minutes before measurement.
- Participants who have exercised immediately before blood pressure measurement.
- Other patients deemed unsuitable for the study at the discretion of the researchers.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gangnam Severance Hospital,
Seoul, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Byoung Kwon Lee
- Organization
- Department of Cardiology at Gangnam Severance hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 30, 2024
First Posted
July 9, 2024
Study Start
April 27, 2023
Primary Completion
October 15, 2024
Study Completion
October 15, 2024
Last Updated
March 3, 2025
Results First Posted
March 3, 2025
Record last verified: 2025-02